KHIRON LIFE SCIENCES CORP (KHRN.CA) Forecast, Price Target & Analyst Ratings
TSX-V:KHRN • CA49374L3065
0.04 CAD
0 (0%)
Last: May 5, 2023, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KHIRON LIFE SCIENCES CORP (KHRN.CA).
Forecast Snapshot
Consensus Price Target
CA$0.10
+ 155.00% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2022
EPS Estimate-CA$0.02
Revenue Estimate3.333M
ChartMill Buy Consensus
45.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$0.10
Upside
+ 155.00%
From current price of CA$0.04 to mean target of CA$0.10, Based on 7 analyst forecasts
Low
CA$0.10
Median
CA$0.10
High
CA$0.11
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for KHRN.CA. The average price target is 0.1 CAD. This implies a price increase of 155% is expected in the next year compared to the current price of 0.04.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
KHRN.CA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about KHRN.CA.
In the previous month the buy percentage consensus was at a similar level.
KHRN.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-08-30 | ATB Capital | Downgrade | |
| 2021-08-24 | ATB Capital | Downgrade | Buy |
| 2021-05-03 | ATB Capital | Downgrade |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2022
EPS Estimate-CA$0.02
Revenue Estimate3.333M
Revenue Q2Q-8.34%
EPS Q2Q45.46%
Number of Analysts2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-20.49%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 20.49% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.582M 974.64% | 8.017M -16.34% | 12.795M 59.60% | 17.776M 38.93% | 24.846M 39.77% | 40.299M 62.20% | 50.266M 24.73% | |
| EBITDA YoY % growth | -36.791M -88.11% | -27.965M 23.99% | -22.38M 19.97% | -11.464M 48.78% | -7.979M 30.40% | 4.343M 154.43% | N/A | |
| EBIT YoY % growth | -37.73M -89.63% | -29.132M 22.79% | -23.495M 19.35% | -15.15M 35.52% | -12.12M 20.00% | 100.00% | N/A | |
| Operating Margin | -393.74% | -363.38% | -183.63% | -85.23% | -48.78% | N/A | N/A | |
| EPS YoY % growth | -0.38 -1.69% | N/A 36.21% | N/A 52.08% | -0.07 39.13% | -0.03 57.14% | 0.00 100.00% | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -0.02 45.46% |
| Revenue Q2Q % growth | 3.333M -8.34% |
| EBITDA Q2Q % growth | -2.727M 52.29% |
| EBIT Q2Q % growth | N/A |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.99%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
45.70%
Revenue Next 5 Year
40.15%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
30.54%
EBIT Next 5 Year
N/A
KHIRON LIFE SCIENCES CORP / KHRN.CA Forecast FAQ
What is the average price target for KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
7 analysts have analysed KHRN.CA and the average price target is 0.1 CAD. This implies a price increase of 155% is expected in the next year compared to the current price of 0.04.
Can you provide the consensus estimates for KHIRON LIFE SCIENCES CORP next earnings?
The consensus EPS estimate for the next earnings of KHIRON LIFE SCIENCES CORP (KHRN.CA) is -0.02 CAD and the consensus revenue estimate is 3.33M CAD.
Can you provide the consensus rating for KHIRON LIFE SCIENCES CORP stock?
The consensus rating for KHIRON LIFE SCIENCES CORP (KHRN.CA) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.